Publication | Open Access
Association Between Immune-related Adverse Events and Clinical Outcome Following Nivolumab Treatment in Patients With Metastatic Renal Cell Carcinoma
18
Citations
18
References
2020
Year
Development of irAEs was associated with survival outcomes of nivolumab treated patients with metastatic renal cell carcinoma.
| Year | Citations | |
|---|---|---|
Page 1
Page 1